TheraRadar

Pharma Intelligence, Simplified

Data updated: Mar 10, 2026

ULTRA-TECHNEKOW V4

TECHNETIUM TC-99M SODIUM PERTECHNETATE GENERATOR Radiopharmaceutical Activity
Metabolic Approved 1973-11-23
Jump to: Indications Approvals Trials Competitors Similar Safety Patents
1
Indication
--
Phase 3 Trials
52
Years on Market

Details

Status
Prescription
First Approved
1973-11-23
Routes
INTRAVENOUS
Dosage Forms
SOLUTION

Companies

CURIUM
Active Ingredient: TECHNETIUM TC-99M SODIUM PERTECHNETATE GENERATOR

ULTRA-TECHNEKOW V4 Approval History

Loading approval history...

What ULTRA-TECHNEKOW V4 Treats

5 indications

ULTRA-TECHNEKOW V4 is approved for 5 conditions since its original approval in 1973. These indications span multiple therapeutic areas including oncology, immunology, and more.

  • Thyroid Imaging
  • Salivary Gland Imaging
  • Urinary Bladder Imaging
  • Vesicoureteral Reflux
  • Nasolacrimal Drainage System Imaging
Source: FDA Label

Drugs Similar to ULTRA-TECHNEKOW V4

FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.

LUMASON
SULFUR HEXAFLUORIDE LIPID-TYPE A MICROSPHERES
1 shared
BRACCO
Shared indications:
Vesicoureteral Reflux
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...
⭐

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

ClinicalTrials.gov ↗ Pro

Full development history with FDA approval milestones

Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

ULTRA-TECHNEKOW V4 FDA Label Details

Pro

Indications & Usage

FDA Label (PDF)

The Ultra-Technekow™ V4 generator is a source of sodium pertechnetate Tc 99m for use in the preparation of FDA-approved diagnostic radiopharmaceuticals, as described in the labeling of these diagnostic radiopharmaceutical kits. Sodium Pertechnetate Tc 99m is used IN ADULTS as an agent for: Thyroid Imaging Salivary Gland Imaging Urinary Bladder Imaging (direct isotopic cystography) for detection of vesico-ureteral reflux Nasolacrimal Drainage System Imaging (dacryoscintigraphy) Sodium Pertechnetate Tc 99m is used IN PEDIATRIC PATIENTS as an agent for: Thyroid Imaging Urinary Bladder Imaging (di...

Want competitive intelligence?

See who's developing similar drugs and track their progress

View Pipeline Dashboard

Data Sources

FDA Approval: NDA017243 → Label: DailyMed → Patents: FDA Orange Book → Trials: ClinicalTrials.gov →

Data sourced from official FDA and NIH databases. Click links to verify on original sources.